Your browser doesn't support javascript.
loading
Inappropriate study inclusion in meta-analysis of sham-controlled rTMS for treatment-resistant depression.
Kennedy, Kevin P.
Affiliation
  • Kennedy KP; Department of Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, USA.
BMC Psychiatry ; 24(1): 247, 2024 Apr 02.
Article in En | MEDLINE | ID: mdl-38566131
ABSTRACT
Dr. Vida and colleagues have published an important meta-analysis on a critical topic in psychiatry the efficacy of double-blind, sham-controlled rTMS in treatment-resistant depression (TRD) [1]. The primary reported finding was a significant effect of rTMS on remission and response (RR 2.25 and 2.78 respectively) compared to sham rTMS. A close evaluation of the studies included in this meta-analysis raises concerns about the accuracy of these findings.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Depressive Disorder, Treatment-Resistant Limits: Humans Language: En Journal: BMC Psychiatry / BMC psychiatry (Online) Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Depressive Disorder, Treatment-Resistant Limits: Humans Language: En Journal: BMC Psychiatry / BMC psychiatry (Online) Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: United States